|
INTERVIEW: Vectura Closer To Finding US Partner For VR315 Lung Drug
Wall Street Journal LN) blockbuster Advair. Novartis AG's (NOVN.VX) generics unit Sandoz relinquished the US rights to VR315 in March 2010 amid uncertainty about the regulatory pathway for bringing cheap versions of popular lung medicines to US patients. … |
|
UK Summary:London Shares Fall -1% Amid Italian Debt Concerns
Wall Street Journal LN) blockbuster Advair. LONDON (Dow Jones)–Bloomsbury Publishing PLC (BMY.LN) said the entire catalogue of newly acquired business Continuum's academic texts will be converted to electronic format within two years, as it attempts to offset volatile … |
|
BEST OF THE BROKERS
CITY A.M. While GSK was the first big pharma company to exit its patent cliff and should return to sales and margin growth this year, the broker believes its mature pharma business is over-valued and downside risks from generic competition to its Advair and … |
www.kiernan-shipka.com / kiernanshipka.com
Video Rating: 0 / 5
Question by Carlos: What are the side effects of using Advair Inhalers?
Im gettting alittle scared now that i found out that Advair inhaler can actually cause death in some people, ive actually STARTED using it a week ago but im planning on to stop, is something gonna happen to me in a long run?????????
Best answer:
Answer by detta
Coughing, bronchitis, thrush, osteoporosis, heart attack are some side effect, check out Drugs.com for more information about Advair.
Advair Information from Drugs.com
Advair side effects. Get emergency medical help if you have any of these signs of an … is accurate, up-to-date, and complete, but no guarantee is made to that effect.
www.drugs.com/advair.html – Cached
Add your own answer in the comments!
Getting the Most out of Dry Powder Inhaler for Asthma and COPD
New York, NY (PRWEB) April 3, 2008
Proper technique is the key to benefiting from dry powder inhalers (DPIs) that treat chronic obstructive pulmonary disease (COPD) and asthma. But data presented at the annual meeting of the American College of Chest Physicians suggest that many patients can’t or don’t know how to use their inhalers properly.
Compared with aerosol metered dose inhalers, DPIs are considered “user-friendly”: They don’t require coordination between breathing in and squeezing the inhaler to release medication, and DPIs rely on your breath rather than chemical propellants to get the medicine into your lungs.
But using DPIs requires a measured, forceful inhalation to ensure that the powdered medication gets from the inhaler to deep in your lungs.
If you inhale too quickly, the powder ends up at the back of your throat; if you breathe too slowly or too gently, it doesn’t go anywhere; and if you accidentally exhale, the powder might get blown away.
Aerosol metered dose inhalers, such as albuterol and ipratropium, give fast relief during acute respiratory attacks, but most DPIs are prescribed to control symptoms. If you are not using your DPI properly, your disease can progress, or you may frequently experience acute episodes that require hospitalization.
Researchers from Offenburg Hospital in Germany reported that 32% of 224 patients made mistakes using their DPIs that prevented them from getting the right dose of medication. Errors were most common in patients who were over 60 and in people with severe lung obstruction.
Each of the various DPIs works differently. Diskus models contain several weeks’ worth of individual doses. Other DPIs look more like traditional tube inhalers and might contain individual doses or need to be loaded with a medication capsule before each use.
If you’re prescribed a DPI, ask your doctor both to show you how to use it and then to watch as you use the DPI yourself. Bring your inhaler to each doctor’s visit to double-check your technique.
Common DPIs include:
Advair Diskus
(salmeterol and fluticasone)
Foradil Aerolizer
(formoterol)
Pulmicort Turbuhaler
(budesonide)
Serevent Diskus
(salmeterol)
Flovent Diskhaler/Diskus/Rotodisk (fluticasone)
If you are having trouble, your doctor can prescribe a traditional metered dose inhaler. Combining this type of pressurized inhaler with a spacer–a device that attaches to the inhaler and holds the medication for a few seconds before releasing it into your airways–can reduce problems with hand-breath coordination.
This article was originally published in The Johns Hopkins Medical Letter: Johns Hopkins Health After 50, April 2008 issue. Copyright 2008
For over 20 years, Johns Hopkins Health After 50 newsletter has been publishing timely information on the health disorders that affect us in later life.
For more information, please visit:
http://www.johnshopkinshealthalerts.com/health_after_50/index.html
For the latest information on COPD, asthma, and other lung disorders from Johns Hopkins Health Alerts, please visit the Lung Disorders Topic Page
http://www.johnshopkinshealthalerts.com/alerts_index/lung_disorders/22-1.html
For a free Special Report, The Johns Hopkins Guide to New Treatments for COPD, please visit:
http://www.johnshopkinshealthalerts.com/ppc/lung_disorders/copdr_reg_landing.html
###
Attachments
©Copyright 1997-
, Vocus PRW Holdings, LLC.
Vocus, PRWeb, and Publicity Wire are trademarks or registered trademarks of Vocus, Inc. or Vocus PRW Holdings, LLC.
